Manuel Rojas

4.1k total citations · 2 hit papers
56 papers, 2.2k citations indexed

About

Manuel Rojas is a scholar working on Infectious Diseases, Immunology and Surgery. According to data from OpenAlex, Manuel Rojas has authored 56 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Immunology and 10 papers in Surgery. Recurrent topics in Manuel Rojas's work include COVID-19 Clinical Research Studies (10 papers), T-cell and B-cell Immunology (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Manuel Rojas is often cited by papers focused on COVID-19 Clinical Research Studies (10 papers), T-cell and B-cell Immunology (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Manuel Rojas collaborates with scholars based in Colombia, United States and Iran. Manuel Rojas's co-authors include Juan‐Manuel Anaya, Carolina Ramı́rez-Santana, Diana M. Monsalve, Yeny Acosta‐Ampudia, Yhojan Rodríguez, Y. Pachéco, Aftab A. Ansari, M. Eric Gershwin, Patrick S.C. Leung and Elizabeth Zapata and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Manuel Rojas

48 papers receiving 2.1k citations

Hit Papers

Molecular mimicry and autoimmunity 2018 2026 2020 2023 2018 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Rojas Colombia 21 983 613 479 335 220 56 2.2k
Yeny Acosta‐Ampudia Colombia 21 1.1k 1.1× 623 1.0× 403 0.8× 341 1.0× 250 1.1× 45 2.2k
Diana M. Monsalve Colombia 23 1.2k 1.2× 633 1.0× 423 0.9× 496 1.5× 211 1.0× 43 2.4k
Yhojan Rodríguez Colombia 22 969 1.0× 634 1.0× 229 0.5× 203 0.6× 168 0.8× 41 1.8k
Patricia Kirby United States 28 629 0.6× 532 0.9× 306 0.6× 601 1.8× 129 0.6× 95 2.9k
Eun‐Suk Kang South Korea 28 873 0.9× 243 0.4× 431 0.9× 406 1.2× 99 0.5× 166 2.6k
Y. Pachéco France 22 490 0.5× 173 0.3× 682 1.4× 355 1.1× 190 0.9× 82 2.1k
Xin Zheng China 22 685 0.7× 253 0.4× 303 0.6× 289 0.9× 161 0.7× 106 2.2k
Francis Corazza Belgium 28 439 0.4× 141 0.2× 386 0.8× 287 0.9× 99 0.5× 93 2.3k
Wei Cao China 18 1.6k 1.6× 572 0.9× 393 0.8× 294 0.9× 46 0.2× 75 2.7k
Pietro Zerbi Italy 23 987 1.0× 502 0.8× 199 0.4× 396 1.2× 44 0.2× 55 2.3k

Countries citing papers authored by Manuel Rojas

Since Specialization
Citations

This map shows the geographic impact of Manuel Rojas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Rojas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Rojas more than expected).

Fields of papers citing papers by Manuel Rojas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Rojas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Rojas. The network helps show where Manuel Rojas may publish in the future.

Co-authorship network of co-authors of Manuel Rojas

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Rojas. A scholar is included among the top collaborators of Manuel Rojas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Rojas. Manuel Rojas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rojas, Manuel, Luke S. Heuer, Weici Zhang, et al.. (2025). Alternate splicing converts human CD137 from costimulatory to immunosuppressive function. Journal of Autoimmunity. 157. 103498–103498.
2.
Zhang, Weici, Patrick S.C. Leung, Koichi Tsuneyama, et al.. (2024). Dietary therapy of murine primary biliary cholangitis induces hepatocellular steatosis: A cautionary tale. Liver International. 44(10). 2834–2846. 2 indexed citations
3.
Rojas, Manuel, Yhojan Rodríguez, Victoria González, et al.. (2024). Predictors of mortality in hospitalised patients with COVID-19: a 1-year case–control study. BMJ Open. 14(2). e072784–e072784. 2 indexed citations
4.
Rojas, Manuel, Yhojan Rodríguez, Mónica Rodríguez‐Jiménez, et al.. (2024). Performance of the Systemic Lupus Erythematosus Risk Probability Index (SLERPI) in a cohort of Colombian population. Clinical Rheumatology. 43(11). 3313–3322.
5.
Calderón‐Ospina, Carlos‐Alberto, Carlos Martín Restrepo, Carolina Ramı́rez-Santana, et al.. (2024). The polygenic implication of clopidogrel responsiveness: Insights from platelet reactivity analysis and next-generation sequencing. PLoS ONE. 19(7). e0306445–e0306445.
6.
González, Victoria, Manuel Rojas, Diana M. Monsalve, et al.. (2024). Prevalence of latent and overt polyautoimmunity in type 1 diabetes: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 18(7). 103087–103087. 1 indexed citations
7.
He, Xiaosong, et al.. (2023). Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis?. Frontiers in Immunology. 14. 1184252–1184252. 13 indexed citations
8.
Acosta‐Ampudia, Yeny, Diana M. Monsalve, Manuel Rojas, et al.. (2022). Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome. The Journal of Infectious Diseases. 225(12). 2155–2162. 109 indexed citations breakdown →
9.
Adams, David E., Luke S. Heuer, Manuel Rojas, Weici Zhang, & William M. Ridgway. (2022). Mutated Pkhd1 alone is sufficient to cause autoimmune biliary disease on the nonobese diabetic (NOD) genetic background. Immunogenetics. 75(1). 27–37. 4 indexed citations
10.
Rodríguez, Yhojan, et al.. (2022). Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review. Journal of Autoimmunity. 132. 102898–102898. 68 indexed citations
11.
Gutiérrez, Carlos Enrique Toro, et al.. (2021). Polymyalgia rheumatica: A case series from Colombia and analysis of Latin America. Journal of Translational Autoimmunity. 4. 100115–100115. 1 indexed citations
12.
Anaya, Juan‐Manuel, Manuel Rojas, Yhojan Rodríguez, et al.. (2021). Post-COVID syndrome. A case series and comprehensive review. Autoimmunity Reviews. 20(11). 102947–102947. 139 indexed citations
13.
Rojas, Manuel & Juan‐Manuel Anaya. (2020). Why will it never be known if convalescent plasma is effective for COVID-19. SHILAP Revista de lepidopterología. 3. 100069–100069. 12 indexed citations
14.
Rodríguez, Yhojan, Manuel Rojas, Diana M. Monsalve, et al.. (2020). Latent autoimmune thyroid disease. SHILAP Revista de lepidopterología. 3. 100038–100038. 11 indexed citations
15.
Rojas, Manuel, et al.. (2019). Vena femoral bitroncular con tronco axiofemoral originado de la vena safena parva. SHILAP Revista de lepidopterología.
16.
Rojas, Manuel, Yhojan Rodríguez, Y. Pachéco, et al.. (2018). Cytokines and Inflammatory Mediators in Systemic Lupus Erythematosus. 83–92. 20 indexed citations
17.
Rojas, Manuel, Paula Restrepo-Jiménez, Diana M. Monsalve, et al.. (2018). Molecular mimicry and autoimmunity. Journal of Autoimmunity. 95. 100–123. 380 indexed citations breakdown →
18.
Pachéco, Y., Julián E. Barahona‐Correa, Diana M. Monsalve, et al.. (2017). Cytokine and autoantibody clusters interaction in systemic lupus erythematosus. Journal of Translational Medicine. 15(1). 239–239. 48 indexed citations
19.
Rojas, Manuel. (2011). Costa Rica: elecciones y democracia en la crisis. SHILAP Revista de lepidopterología.
20.
Rojas, Manuel, et al.. (1957). Antología de cuentos.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026